BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12805023)

  • 1. Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells.
    Lum H; Qiao J; Walter RJ; Huang F; Subbaiah PV; Kim KS; Holian O
    Am J Physiol Heart Circ Physiol; 2003 Oct; 285(4):H1786-9. PubMed ID: 12805023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4.
    Qiao J; Huang F; Naikawadi RP; Kim KS; Said T; Lum H
    Am J Physiol Lung Cell Mol Physiol; 2006 Jul; 291(1):L91-101. PubMed ID: 16461426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4.
    Zhu K; Baudhuin LM; Hong G; Williams FS; Cristina KL; Kabarowski JH; Witte ON; Xu Y
    J Biol Chem; 2001 Nov; 276(44):41325-35. PubMed ID: 11535583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel lysophospholipid- and pH-sensitive receptor, GPR4, in brain endothelial cells regulates monocyte transmigration.
    Huang F; Mehta D; Predescu S; Kim KS; Lum H
    Endothelium; 2007; 14(1):25-34. PubMed ID: 17364894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidylcholine induces apoptosis and inflammatory damage in brain microvascular endothelial cells via GPR4-mediated NLRP3 inflammasome activation.
    Liu T; Wang X; Guo F; Sun X; Yuan K; Wang Q; Lan C
    Toxicol In Vitro; 2021 Dec; 77():105227. PubMed ID: 34293432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action mode of lysophosphatidylcholine in human monocytes.
    Yun MR; Okajima F; Im DS
    J Pharmacol Sci; 2004 Jan; 94(1):45-50. PubMed ID: 14745117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques.
    Rikitake Y; Hirata K; Yamashita T; Iwai K; Kobayashi S; Itoh H; Ozaki M; Ejiri J; Shiomi M; Inoue N; Kawashima S; Yokoyama M
    Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):2049-53. PubMed ID: 12482833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylcholine increases endothelial permeability: role of PKCalpha and RhoA cross talk.
    Huang F; Subbaiah PV; Holian O; Zhang J; Johnson A; Gertzberg N; Lum H
    Am J Physiol Lung Cell Mol Physiol; 2005 Aug; 289(2):L176-85. PubMed ID: 15764646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone.
    Hartmeyer M; Scholzen T; Becher E; Bhardwaj RS; Schwarz T; Luger TA
    J Immunol; 1997 Aug; 159(4):1930-7. PubMed ID: 9257858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidylcholine enhances the suppressive function of human naturally occurring regulatory T cells through TGF-β production.
    Hasegawa H; Lei J; Matsumoto T; Onishi S; Suemori K; Yasukawa M
    Biochem Biophys Res Commun; 2011 Nov; 415(3):526-31. PubMed ID: 22074829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of NF-kappaB induced by H(2)O(2) and TNF-alpha and its effects on ICAM-1 expression in endothelial cells.
    True AL; Rahman A; Malik AB
    Am J Physiol Lung Cell Mol Physiol; 2000 Aug; 279(2):L302-11. PubMed ID: 10926553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines.
    Murugesan G; Sandhya Rani MR; Gerber CE; Mukhopadhyay C; Ransohoff RM; Chisolm GM; Kottke-Marchant K
    J Mol Cell Cardiol; 2003 Nov; 35(11):1375-84. PubMed ID: 14596794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines.
    Goebeler M; Yoshimura T; Toksoy A; Ritter U; Bröcker EB; Gillitzer R
    J Invest Dermatol; 1997 Apr; 108(4):445-51. PubMed ID: 9077472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.
    Kabarowski JH; Zhu K; Le LQ; Witte ON; Xu Y
    Science; 2001 Jul; 293(5530):702-5. PubMed ID: 11474113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eotaxin/CCL11 suppresses IL-8/CXCL8 secretion from human dermal microvascular endothelial cells.
    Cheng SS; Lukacs NW; Kunkel SL
    J Immunol; 2002 Mar; 168(6):2887-94. PubMed ID: 11884459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine.
    Murakami N; Yokomizo T; Okuno T; Shimizu T
    J Biol Chem; 2004 Oct; 279(41):42484-91. PubMed ID: 15280385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the beta-chemokines RANTES and MIP-1 beta by human brain microvessel endothelial cells in primary culture.
    Shukaliak JA; Dorovini-Zis K
    J Neuropathol Exp Neurol; 2000 May; 59(5):339-52. PubMed ID: 10888363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of tissue factor in microvascular dermal endothelial cells.
    O'Reilly FM; Casper KA; Otto KB; Sexton SA; Swerlick RA
    J Invest Dermatol; 2003 Mar; 120(3):489-94. PubMed ID: 12603864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin-induced release of lysophosphatidylcholine from endothelial cells.
    McHowat J; Corr PB
    J Biol Chem; 1993 Jul; 268(21):15605-10. PubMed ID: 8393449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of lysophosphatidylcholine (LPC) in atherosclerosis.
    Matsumoto T; Kobayashi T; Kamata K
    Curr Med Chem; 2007; 14(30):3209-20. PubMed ID: 18220755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.